Aalto Bio is amongst a number of companies working on a vaccine for COVID-19.
The Dublin-based biotech company researches and develops proteins and reagents that are provided to pharmaceutical companies that in turn develop diagnostic tests for viruses.
CEO of Aalto Bio, Philip Noone who has been working in the virus diagnostics space for twenty-five years, says his company has been working on the clinical trials with a couple of companies who are developing vaccines. They include the American pharma giant, Moderna.
Noone told Sonya Lennon, host of The Architects of Business, made in partnership with EY Entrepreneur Of The Year™, about the pace at which the vaccine development is happening:
“Moderna have done their phase two clinical trials. You do three phases of clinical trials before you bring the product to market.
“They’re in their third phase and they’re probably moving at a speed faster than anybody else.
“So, we’ve been working hand in hand with them, helping them with their clinical trials in order to get a vaccine on the market faster. “
He goes onto explain on the podcast why he thinks a vaccine will be available before the end of the year.
Watch the interview here.
Listen to the full interview with the 2019 finalist in the EY Entrepreneur of the Year™ programme below.
** Philip begins talking about the search for the vaccine from 30.15 onwards.**
Subscribe to The Architects of Business for free on Apple Podcasts, Google Podcasts, Spotify, or watch every episode on YouTube.
